Skip to main content
. 2012 Jul 27;7(7):e42100. doi: 10.1371/journal.pone.0042100

Figure 2. Evaluation of IFNα and ApoAI biological properties.

Figure 2

A. recombinant IFN (rIFN), GFPApo, IFNGFP and IFNGFPApo antiviral efficacy against encephalomyocarditis virus expressed as percentage of surviving cells against molecule dilution. B. Determination by ELISA of the IFNα content of the different plasma lipoprotein fractions obtained after 24 h of hydrodynamic injection of 20 µg IFNGFP or IFNGFP plasmid. Pooled samples of three mice per group were used. C. Western blot against ApoAI of HDL plasma fractions obtained as previously described.